Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 59.70 |
| Open | 61.56 |
| Bid | 62.00 x 1300 |
| Ask | 62.40 x 1300 |
| Day's range | 60.28 - 63.80 |
| 52-week range | 58.93 - 96.12 |
| Volume | |
| Avg. volume | 3,496,080 |
| Market cap | 37.584B |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 26.10 |
| EPS (TTM) | 2.39 |
| Earnings date | 23 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 82.05 |
Investor's Business DailyEdwards Crashes 31% After Slashing Guidance For Its Biggest Moneymaker
Edwards Lifesciences stock plummeted Thursday after the medtech cut its outlook for TAVR sales following a mixed second-quarter report.
Barrons.comEdwards Lifesciences Stock Plunges 28% After Earnings. What Wall Street Thinks.
FEATURE Shares of Edwards Lifesciences fell sharply after the medical-technologies company’s quarterly earnings report and guidance left investors disappointed. For its second quarter, ended June 30, the company reported adjusted earnings per share of 70 cents, beating Wall Street’s forecast by a penny, according to FactSet.
ZacksEdwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash
Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.
© 2024 Yahoo. All rights reserved.